Buffi's Profile
Displaying 1-50 of 462 result(s).
Recent Articles
- ImCheck Therapeutics Showcases Promising AML Therapy Results
- Legend Biotech Reveals Significant Updates in Cancer Treatment
- ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
- Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
- Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
- Acceleware Ltd. Achieves Significant Progress in Q1 2025
- Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
- Petrus Resources Shares Success of Annual Meeting Outcomes
- Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
- Candel Therapeutics Advances Localized Prostate Cancer Treatment
- Adagene Showcases Promising Results for ADG126 in Cancer Trials
- Banco Comercial Português Highlights Key AGM Resolutions
- Wheaton Precious Metals Unveils 2024 Reports on Sustainability and Climate
- Novita Reports Encouraging Phase 2 Trial Results for NP-G2-044
- Accent Therapeutics Showcases Innovative Cancer Treatment Advances
- Cizzle Bio's CIZ1B Test Offers Significant Medicare Savings
- Ontario International Airport Sees Record Passenger Growth
- Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL
- XTANDI™ Breakthrough: Prostate Cancer Patients See 30% Survival Increase
- Servier Showcases Commitment to IDH-Mutated Cancer Research
- West Fraser Timber's Commitment to Sustainability in 2024
- Boehringer Ingelheim's Ambitious Plan for Future Cancer Innovations
- Taiho Oncology Unveils Groundbreaking Cancer Therapy Data
- Eli Lilly Unveils Research Presentations for ASCO 2025 Meeting
- COOFANDY Celebrates a Decade of Excellence with Major Awards
- Unlocking Earning Potential: FioBit's AI Mining Revolution 2025
- Unlock Passive Income with PAIRMiner's Cutting-Edge Mining
- THOR Industries Prepares for Upcoming Q3 2025 Earnings Call
- Clear Blue Technologies Plans Corporate Update and Q1 2025 Report
- Bicara Therapeutics Shares Key Data on Ficerafusp Alfa Therapy
- Northview Residential REIT Declares Latest Distribution for Investors
- Zymeworks Showcases Cancer Treatments at Major Medical Events
- VCI Global's Equity Agreement Revamped for Strategic Growth
- Innovative Treatment Combines Linvoseltamab with Proteasome Inhibitors
- Stephen Brannan Joins Serina Therapeutics Board for Growth
- Onconetix Inc. Faces Delisting Notice from Nasdaq Amid Compliance Issues
- Cal Redwood Acquisition Corp. Successfully Prices $200 Million Offering
- Gemspring Capital Expands Portfolio with Goodyear Chemical Acquisition
- Life Time Eagle: A New Era for Health and Wellness In Idaho
- RNR Tire Express Celebrates Community Impact and Awards
- Southwest Airlines to Discuss Strategic Plans at Major Conference
- Transforming Global Payments: How TransFi's BizPay Innovates Business Transactions
- First Capital, Inc. Declares New Dividend for Shareholders
- Biodexa Pharmaceuticals' Upcoming General Meeting Announced
- Interpublic Board Approves Quarterly Dividend Payment Announcement
- Bio-Path Holdings Discusses Key Developments in Upcoming Call
- Crown LNG Holdings Limited Updates on NASDAQ Compliance Status
- Red River Bancshares, Inc. Engages in Significant Stock Buyback
- Medallion Bank Successfully Completes Series G Stock Offering
- Athene Holding Ltd. Announces Dividend for Preferred Shares
